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Cornnary balloon angioplasty constitutes a definitive ad- 
vance in the treatment of coronary artery disease. Despite 
improvements in technique and equipment, restenosis re- 
mains a major limitation of cormxwy balkan an&play 
(I-3). Various new mechanical appmwhes have been under- 
taken to prevent restenosis but withwt pmved eikacy. One 
such device, the F’abttwSchatz stem. is reported m be 
e&&e in optimizing the initial lumen result after balloon 
angioplasty (4,s. Although its efficacy in preventing resten- 
osis is not yet established, several observational reports 
(4.6-9) suggest a promising result in this respect. To evalu- 
ate the tempcd mode oilumen diameter changes after stent 
placettwtt.~we performed serial angiiographic folhw-up on 
the next day and at I, 3 and 6 months atIer Palmaz-Schatz 
stat implantation. The data were revospedively compared 
qualitative and quantitative ditferencesin 
. 
restenosis. 
stem cases. Successtid statt @bmtakn was de&fed as 
successf!Jl delivery of sknts tuKl residusl htmen dianteter 
stermsis of <X3%. Pnxedural success was achieved in % 
jaients with 97 lesions (97%). Sub%cnte stettt thmmbcsis 
occurred in four kkns (4.1%). AU fan stem wcrc sums_+ 
fullyreopenedbyintnraonsrylhrombdysis~repated 
balloondilatim,ort.ah.Tl!utfm,97IesEohnwerepatmtal 
the time of hospital disch9iw. Tk Palmaz-Sclxtz stettt awp 
consistedofthese%p&ntswitb97!&ons. 
Convenlionol balhmd angio&g, group. Between Jaw- 
at’y 19868ndAugust 1%6,54+tientsur&ruentsuccessful 
balloon angicqdwty. Two-hundred twenty-nim patients with 
288 lesions were prospectively enrolled bt a serial an& 
graphic follow-up study. The r&tr from the total group 
have been published elsewhen (I). To eliminate small-sized 
arteries and diiuse disease unfavorable to stmt implant-a- 
tion, a who;: d 179 patients with 192 lesions were selected 
by the criteria of final halloon size a3 mm and lesion lettgth 
<20 mm. Patiettts and the responsible relatives gave in- 
formed consent to the interventional procedure and the 
follow-up protocol. The institutional ethical committee ap- 
moved the study protocol. 
Stent plac&ai. All steat implaatation procedures were 
performed using the Johnson & Johnsan Sent delivery system 
&d standard t&hniques (9). When further expansion of the 
steat wasc~lsidered necessary at&initial stent deployment, a 
larger balloon catheter was used to overexpand the steat. 
Pharmaeakgkmaaagammt. Routine antiangiaal mediia- 
tions consisting of long-acting nitrates aad calcium channel 
antagonists w&e cmtimed. At least 1 day before the pro- 
cedure, a&in, 240 mg, and dipyridamok, 75 m& were 
initiated as~antiplatelet (herapy. I& molecular weight dex- 
tran was administered by intravenous infitsion starting 2 h 
before the prowdun and continuing for a total dose of 
500 ml. At the time ofarterial access, heparin, IO,WlO U, was 
injected by way of the femoral artery sheath. Intracoronaty 
isosorbide dhdtrate, 2.5 mg, was administered before control 
aagwgraphy and afta the procedure. The same protocol with 
regard to kosmbide diaitrate was ased at all sabscqucnt 
follow-up studies. Immediately after stent implantation, iaha- 
venous hepadn infusion, 200 lJ,#g per day was started, aad 
atkr sheath removal on the next morning the heparin dose was 
adjusted to keep activated partial thmmb@astin time at 60 to 
Bo s. Intravenous heoarin infusion was c&wed uMLl oral 
amicoagulant (Coum&m) therapy achieved therapeatk a&t 
larothrombin time 16 to I8 s). Coamadii was continwxl for 3 
ioaths. In patients anderg& convent&al ballwa angio- 
p&y, inhavenous heparin infusion was performed only when 
angiographic evidence of dissection was noted. Coamadin was 
not admiaistered after cowantioaal balloon angioplasty. 
S&l cwaaaty aag@aphy. Follow-up aagiogr&y was 
performedonthenextdayandal1.3and6monthrafterthe 
pmcedure regatxlless of patients’ symptomatic status. Fdlow- 
UP an&waohy was oerfomwd on an oatoatient basis with we 
2 a jF_f&&al a; a 6F brachial di&oslk catheter. nK 
nstady rate of each cohmt is shown in Table I. The lower 
restudy rata on the next day and at I month ln the stent grwp 
was due to uaeqaivocal results obtained t?om earlier patkats. 
l-he protocol of angiogmphy on the next day aad at I moath 
was discarded a, later patients. Followup aa&rams at 3 and 
6 months were available in >90% of patients i  both gmaps. 
Measawaant af camaary skamk. Severity of coronary 
stenotic lesions in the balloon group was assessed by qaan- 
titative coronary angiography with cinevideodensitometric 
analysis using the Vanguard XR-70 coronary analyzer. De- 
tails of measurement have been reported previously (I). 
Stenosis measurement in the stent groap was performed by 
calipers. A worst view after stent implantation WBI selected 
from multbxoiections. Stenosis measurement of control aad 
follow-up aneiograms was perfmed in nearly identical 
views. Absolute lumen diameter was calculated from the 
known diameter of the @ii and diagno& catheters. The 
r$erence diameter was measured at the proximal or distal 
segment that was apparenlly free of disease.. The stenotic . _ . 
Table 1. FollwUo Aoeiwaohic Protocol 
nearby nonstented area. Angiograpkic restenosis was de- 
fined as &% diameter stenosis anywhere within or adia- 
cent to the stented segment. The (crate gain in h&n 
diameter was defined as the diierence in minimal stenosis 
diameter before aad atkr the wocedare. The fore loss was 
de&d as the difference be&n stenosis diameter atler the 
pmcedwe and that at follow-up. 
StaWkal aaaJysk. Values are expnssed as maaa value 
2 1 SD. Categoric variables were analyzed by the ehi-square 
test. Continuous wiabks were analyzed with a hvc-factor 
analysis of variaace: p < 0.05 was regarded as signi6caat. 
ChIcal rwdk d stonl #amat. Falmaz-Schatz stent 
implaatatioa was attempted in 99 patients with I60 lesioas. 
Seventy-four stents were attempted ekctively and 26 stents 
in the emergency settiag of occlasioa or dissection afler 
baIIooaaa&plasty,mbothoth. Inthreeksions,thestaatcoald 
not be delivered owing to proximal vessal tortaosity. There- 
fore. procedural success wa achkved in 96 patknts with 97 
kaions (97%). Pmeedwal swcess was obtained in all 74 
ksions for ekctive stenting, and in 23 of26 ksioas (W6)for 
emergency pmceduns. -Illerr were no acute vessel closures 
within 24 h after swcesafal 8tem Im@atatka. Than were 
fear sobacuta thmmlwtk clowes (4.1%) between 5 aad 7 
days after the procedure. ‘I’lx subacute thrombosis rate was 
1.4% ia ckctb-i stenting in contraat to 13.0% in emugeacy 
procedures. Stent-related myocardii infarction occured in 
six patients (6.2%). The catws of atent-related myocafdii 
infarction were subacule thmmbosis in three patients, side 
branch occlusion in two patients aad vessel cloawe alter 
unsaccessful stent delivery in one patient. Then were DO 
emergency bypass operations aria-hospital deaths. Bleeding 
com~licafions reauirina blood tmasfoska or w&al reoah 
occ&ed in two &et& (2.1%). 
_ . 
Ba5dlaapalklltaadk8ka -iT*z). Bass- 
line oatient aad lesion chamcteristka diiered in saveral 
asp&s in UK two gmops. Mean aga was slgaiitly higher 
is the s(enl goup, and this gmap incladed significantly more 
palimls with preview coronary aagiaplasty and fewer pa- 
tients with acute myocardial infarctioa. The steat groi8p 
included significantly more Idt main cornnary artery ksioas, _ . _ 
segment was selected from both the stented portion and the fewer left circamlkx artery lesioes and more rasteaotic 
Table 2. BaseLine Patient and Lesion Ctarxtaistics 
8ignlltly greater in the stent group. 
Mtatastmwb-kfprr,*rstcnt 
htt@udatbaudat3to6tttaWaffotfar-~~(nb.1). 
Minimal stenosis diameter before the procedure was not 
Ftfwe 1. Changes in ndnimal ~tewxis diameter before (FE), atler 
(Posl) and at 3 to 6 months of f&w-up aRer Paimaz-Schatz stent 
implantation (opetn ctrctta) and bidloon an&tasty (tdid ctrfks). 
different between the balloon and stent groups. A sign& 
catty :argx lumen diameter was obtakd immediately atkr 
stat implantation (2.9 f 0.4 mm in the stat group vs. 2.1 1 
0.5 mm in the balloon group: p < 0.000. At 3 to 6 months of 
follow-up, a sigrtikantly larger lumen was ntaitttaittcd in the 
stent group (2.2 + 0.6 vs. 1.5 2 0.7 mm. p < 0.001). Acute 
gain in lumen diameter was si&icantly larger in the stetn 
group(2.2 2 0.5”s. 1.3 i: 0.6mm;~<O.O01~. Latelosswas 
also significantly greater in the stat grwp (0.7 + 0.6 vs. 
0.5 + 0.7 mm, p < 0.01). Late reslenosis rate according to a 
binary definition was sinnificantlv low in the stent FZTOUD 
(!2 t13w of % vs. 74 IS51 d 191, p < 0.001) (Fig. 5. 
ChWl@Sil4ttdb8l~Iliue*rbl&kbr.~ 
iutervat il?g. 3). Between the period immediately after 
balloon anpioptasty and the next day. minimal stenosis 
F&we 4. Changes in minimal stenosis diametcx (A MSD) between 
the period immediately after (F’os!) the procedure and the next day. 
., stenr group. b, Balloon angioplasty group. 
diameter tended to decrease (-0.24 5 0.39 mm) (F&4). In 
contrast to this tendency toward stenosis exacerbation in the 
balloon group, stenosis diameter in the stent 8rottp was 
remarkably constant during tbis interval (-0.04 t 0.18 mm). 
Siiiftcant loss of diameter in two cases wgs observed, not 
inside the stats but at the junction of tbe stented and 
nonstentcd portion of the artery. Between tbe next day and 
I month follow-up, stfoosis diameter tended to increase in 
the balloon group and decrease in the stent group (0.13 L? 
0.46 vs. -0.17 C 0.3 mm) (Fi& 5). Between I and 3 mootbs, 
the grea’est tendency to restenosis wgs observed in both 
groups (-0.42 f 0.51~3. -0.37 2 0.41 am) (Fig. 61. Despite 
ihis &meter lass, most lesions in the steni &phustai~ed 
g.ood patency. Between 3 and 6 months, stenosis diameter 
remained relatively constant in both 8roups (Fig. 7). Iiow- 
over, mean loss of diameter was significantly greater in the 
stent 8mop (-0.03 + 0.36 vs. -0.16 * 0.32 mm). 
Prevention of restehosls bv the Palmaz&batz stat. The 
idea of preventing restenoi by implanting a stent was 
introduced by Dotter and Judklns in 1964 (IO). Correntlv. 
several stent designs are under clinical i&e&&o. Si8w& 
et al. (11) retmrted the first implaota~ion of self-expanding 
Flew 5. Changes in minimal steoosis diameter between the oat 
day and I month after the procedure. a, Slent grow. b. Balloon 
adplasty group. Abbrevir~tion~ as in Figure 4. 
stents in the uwxmry cirwlation of humans. Senuys ct al. 
(12) reported angiograpbic follow-up results of piawoent of 
a self-expanding stunt. &spite an apparently prontisin8 late 
restenosis rate (14%). an unacceptably biih stent tbmmbosis 
rate (24%) makes these data dislcult to interpret. Roobin et 
al. (13) reported a late nstenosis rate of iI%, with 76% 
angw8mphtc follow-up after balloon-exprmdablc coil stent 
implantation io bailoot situations. With regard to tha Palmae- 
Scbatz stent, long-term angiograpbIc follow-up rest&s in 
lat8e patient series are not yet folly availabh?; however, the 
data to date suggest that the P&az-Schatz stat is pmmi~ 
ing in preventin restenosis. Carrozza et al. (9) reported g 
25% restenosis rate in I17 lesions. Matz et al. (7) reported 
a 20% restenosis rate in 103 patients with singk.stent im- 
plantation. Iiaude et al. (8) reported a 15% astenosis rate in 
33 patients. Ovr data of a 13% restenosis rate in 109 lesions 
with 98% angiographic followup ate comparable to those 
restenosisfigures. Ofcwrse, it is premature toconclude that 
tbe Fnlmaz+ichatz stem really reduces the Iale restenosis 
rate afterbalkat arwdoplasty. In the present study. there are 
several important diietw!ces in the baseline chamcteristics 
between the stcnt and ballown groups. Tzlc s1ents were 
implanted preferentially in disc& reg& in larger arteries. 
Lesion len8tb and arterial diemete.. are reported to be 
significant prediaors of restenosis (3). whereas a 5% ioci- 
Rpre 6. Changes in mininxd stewsis diameter between I and 3 
months after the pmeedure. 1. Sent gmup. b, Battoon angi+plasty 
5vup. Abbreviations as in Fii 4. 
F@re 7. Changes in minimal stm& dkneter between 3 and 6 
months afkr the poeedure. a, Stsot g,c,,p. b, B&a,, agi@z&y 
group. Abbreviations as in t+‘%urs 4. 
dettCe of~SktWiC lesions in the steot pop is considered to 
be prcdkposing to an increased iaeidetta of resteoosis. In 
Ihe ftttur~. ~arcfully de&& raodomized trials will clarify 
the true resteoosis rate of the Palmaz-Sehatz stent in a large 
Pf~tiCot Cohort cotn~ble to talloott angioplasty. At this 
point, however, 8 t’cs!enoois rate of <2@% in a highly 
sekctcd cohort of patkots seems to be a remarkable step 
toward prevention of restenosis. 
The mechaoisms of resteoosis prevention, if it o~cttrs at 
all. ttfler Palmakhatz stent implant&o are nat folly 
uoderstorxl. Schatz (14) postulated in his early report that 
nontkxhtg rigid stents may create a lo&iii n&lo of 
rcdoced wall stress, thus inhibiting the cascade of events 
pmduc@ atbemsckmsis. Levim et rd. (4). however, rc- 
ported ra 0.4@ to O&l-mm thickness of the mdntimal layer 
within even 1bos-z stents free of restenosis. Recently, Kuntz 
et al. (15) intrcdttced tba terms ‘M~tegain” and “late loss.” 
They compared the apparent restenosis rates aomog the 
tbtee inlerventions(l918forstents, 3l%foratherectomy and 
SO% for laser balloon ao&ksly). They concluded that the 
observed diUerences in restenosis tate coold tx explaioed by 
the diEenoccs in acute &tt rather that late loss. Also in the 
prKat study, IHe lumen loss was signilicantly greater in the 
stat gm+~p than ia the balloon grottp. Acute lumen pain, in 
con@r.t, was markedly greater in the stcot groop. There 
fore, the predomioant mechanism of prrveatiog nstenasis 
was considered to be aCpeoderd ott its etIkacy io optimidsg 
the ittidal lumen gmmetry. Siy greater late bxs io 
the stent goop was compensated by moth gtater acute 
pain. Beatt et al. (16) rcpmled paradoxk itt~reax in resten- 
osis rate by a ctitcrlon of loss of att absohtte htmcn dianxter 
~0.72 mm when a large bnpmvement io the minimat lumen 
diameter was obtained at the time of balkon angkpksty. A 
larger aaoe gain is coosidued to be asmciated with more 
extensive vasctdar injory, resulting itt greater late iotirttal 
hyprplasia.Kuntletal.(17)~patcdthatlstelossisrel~ted 
to a~ote gain by a fpctor (the loss index) whose value for 
both stating and balloon angio&sty is appmximately 0.4. 
This rcktioo correlated well with the obsetvrd late losses 
Seen in our sludy. 
dent. The ?ehnaz-Schatz stat, however, has an articulation 
point, end significant recoil is usually found at this point after 
overdilation. Banner et al. (18) also reported 16% recoil in the 
ate period after Pelmaz-Schatz stent implantation. 
From immediately afrer fhe procedure to the next day. 
During this period, minimal stenosis diameter tended to 
decrease after balloon angioplasty. Postulated mechanisms 
of this early exacerbation of stenosis we elastic recoil, 
thrambus formation end propagation of dissection. This 
early progression of stenosis was. not observed after stent 
implantation. A scaffolding effect of the implanted stent is 
considered to prevent recoil and propagation of dissection. 
Also, thrombus formation within 24 h might well be limited 
to such a small extent that it is undetectable by angiography. 
From fhe nexf day fo I monfh. During this interval, 
stenosis diameter tended to improve titer balloon an& 
ok&v. Patholoaic studies (19,201 have shown intimal rrrolif- 
km&n of m&h muscle cells to be active during this 
interval. Stenosis improvement during this interval could 
possibly be explained by the favorable remodeling of the 
disrupted intima or resolution of thmmbus. In cantrest to 
balloon angioplasty, significant progression of stenosis was 
observed in this interval atkr stent implantation. Schatz et 
al. (21) reported that after experiment&stent implantation in 
canine coronary arteries, myofibroblastie cells replaced 
thrombus at 3 weeks. Morphometrically measured neoimi- 
mal thickness at 3 weeks approximated 0.08 mm. This 
neointimal thickness correlated well with our mean lumen 
diameter loss of 0.22 mm at I month. 
Between I and 3 months. The greatest tendency to 
restenosis was observed both after balloon angioplasty end 
Pelma&Schatz stem implantation during this period. His- 
topathologic findings of stent restenosis in human coronary 
erteries are not vet well described. Banner et al. (18) 
suggested that chrbnic stent compression rather then intimal 
hyprplasia is the principal cause of stent restenosis. Stew 
diameter was not measured in the present study because the 
Palmaz-Schatz stent is only faintly &opaque, and mea- 
surement of stent diameter is not reliable with current 
radiographic equipment. However. in an experimental 
study, Schatz et-a< (21) reported intense iibrohl&t pmlifer- 
ation at 8 weeks after Stat implantation. Prwression of 
stenosis during this interval se&s that the s&e me&a. 
nism of restenosis as that with b&on angiaplasty (prolifer- 
ation of smooth muscle cells) is responsible for stent resten- 
osis. 
5crween 3 and 6 months. During this period, stenosis 
diameter was relatively constant in both groups, but mean 
loss of diameter was significantly greater in the stent group. 
Schatz et al. (21) reported sclerotic change and marked 
regression of neointima between g and 32 weeks after 
experimental stent implantation. This regression was not 
observed in human athemsclemtic cornnary arteries, at least 
up to 6 months. Greater lass of diameter during this interval 
after stent implantation is difiicult to interpret. In the balloon 
group, most patients with lesions with a high proliferative 
potential dropped out at 3 months owing to angiogxaphic 
restenosis. In the stent group, even those highly proliferative 
lesions might remain patent owing to alargerlumen obtained 
immediately after the procedure. Inclusion of these lesions 
predisposing to restenosis might be related to greater diam- 
eter loss between 3 and 6 months after stem implantation; 
however, only about 15% of the total diameter loss by 6 
mouths occurred between 3 and 6 months, suggesting that 
this process should have been completed by 6 months. Leon 
et al. (22) reported the result of lunger term au&graphic 
follow-up, showing no further reduction in lumen diameter 
after 6 months. F’wiuusly, we recommended follow-up 
angiography at 3 months after ballwn angiaplasty to detect 
restenosis earlier. Considering the much lower restenusis 
rate and minimal but nonnegligible progression until 6 
mouths, the resteuusis rate after stating sbuld be evalu- 
ated by follow-up angiognphy at 6 months. 
Shwly l&ndtaUom. This study has several important limi- 
tations. I) Although serial ausiographic follow-up was de- 
signed prospectively, comparison of the balloon and stmt 
gmups was retrospective. Sekctiw criteria for the balloon 
P~UD were arbitw. 2) There were several imwrlant 
diffe&es in base&e ~haracteristks between tie two 
groups. The restenusis rate is reported to be influenced by 
several vurkbks, such as lesion length and lacatiun. vessel 
size and severity of stmosis before the procedure. To 
evaluate differences in restenosis rates, a comparison must 
be made between the two groups matched fur these bus&e 
characteristks. 3) Stenosis in the stat gruup was measured 
with calipers, whereas viikodensitometry was utilized in the 
balloon group. After balloon awioplasty, the an&r@ic 
appearance of the dilated ksions is dten shaggy and hezy. 
making caliper measurement le.55 accurate. Caliper measure- 
ments, however, rue reliable for measuring the round, 
smooth lumens such as those that occur eikr stent implan- 
tation. 4) The sampk size is still too smell to identify the 
actual nstenasis rate uf the Puhnaz-S&a@ stent. In addi- 
tion, must ksions were careftdly sekcted for stent implen- 
tation. The present results are ml directly ap&abk to 
smaller arteries and lunger Icsiuns. Despite these study 
limitatiuns, promising results in preventing restenusis war- 
runt continued clinical research and mndumized trials with 
other interventional devices. 
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